載入...
BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES
Despite improvements in early detection and intervention, breast cancer remains the second leading cause of cancer-related death in women and the second most common cancer to metastasize to the brain. Current standard of care options for breast cancer brain metastases (BCBM) include stereotactic rad...
Na minha lista:
| 發表在: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213346/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz014.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|